Use App
Trending
News
Earnings
All
DIA
1.05%
SPY
0.13%
QQQ
1.73%
Trending
DASH
1.66%
BA
3.62%
PEP
2.17%
DOGE
1.79%
XBI
2.50%
YINN
0.85%
TSLL
15.17%
PENG
10.67%
UVXY
1.55%
UNH
0.28%
DASH
1.66%
BA
3.62%
PEP
2.17%
DOGE
1.79%
XBI
2.50%
YINN
0.85%
TSLL
15.17%
PENG
10.67%
UVXY
1.55%
UNH
0.28%
Feed
News
Sentiment
Fundamentals
Info
home
Symbol
LLYX
news
Exchange:
NYSEArca
·
Updated 07:54 PM EDT
LLYX
Defiance Daily Target 2X Long LLY ETF
$28.21
$0.86
(3.14%)
Today
·
Closed $28.21
$0.0891
(0.32%)
After Hours
1
2
8
1
2
8
Vol
530,971.00
52W High
$29.52
52W Low
$9.60
News
all
press releases
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
Fourth-quarter revenue surged 43% to $19.3 billion, above Street estimates of $17.86 billion, according to Fiscal.ai data.
Stocktwits
Full Article
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Stocktwits
Full Article
<
...
1
>
Advertisement
|
Remove ads.
Latest LLYX News
View
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
Stocktwits
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
Stocktwits
Loading...
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile